Skandinaviska Enskilda Banken (SEB)
ANIP icon

Skandinaviska Enskilda Banken (SEB)’s ANI Pharmaceuticals ANIP Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,500
Closed -$910K – 796
2023
Q4 		$910K Buy
16,500
+4,700
+40% +$259K 0.01% 707
2023
Q3 		$685K Buy
+11,800
New +$681K ﹤0.01% 731
2020
Q4 		– Sell
-4,800
Closed -$135K – 1129
2020
Q3 		$135K Buy
+4,800
New +$143K ﹤0.01% 925
2019
Q3 		– Sell
-28,600
Closed -$2.35M – 916
2019
Q2 		$2.35M Sell
28,600
-15,500
-35% -$1.1M 0.02% 464
2019
Q1 		$3.11M Sell
44,100
-2,600
-6% -$153K 0.03% 366
2018
Q4 		$2.1M Buy
46,700
+6,200
+15% +$325K 0.02% 463
2018
Q3 		$2.29M Buy
40,500
+6,700
+20% +$410K 0.02% 447
2018
Q2 		$2.26M Sell
33,800
-5,300
-14% -$331K 0.02% 405
2018
Q1 		$2.28M Buy
39,100
+1,500
+4% +$95.2K 0.02% 375
2017
Q4 		$2.42M Sell
37,600
-17,300
-32% -$1.08M 0.02% 400
2017
Q3 		$2.88M Buy
54,900
+25,300
+85% +$1.21M 0.03% 389
2017
Q2 		$1.39M Buy
29,600
+24,800
+517% +$1.2M 0.01% 548
2017
Q1 		$238K Buy
+4,800
New +$270K ﹤0.01% 719
2016
Q3 		– Sell
-47,500
Closed -$2.65M – 708
2016
Q2 		$2.65M Sell
47,500
-81,500
-63% -$3.96M 0.03% 385
2016
Q1 		$4.34M Sell
129,000
-13,900
-10% -$471K 0.05% 266
2015
Q4 		$6.7M Buy
+142,900
New +$6.15M 0.09% 178

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ANIP Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of ANI Pharmaceuticals (ANIP) in Q1 2024, closing a stake of 16,500 shares — an estimated $910K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ANIP in Q4 2015 and held it in 16 quarters. The position peaked at $6.7M in Q4 2015. 200 funds tracked by Wall St. Rank hold ANIP as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining ANI Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 16,500 ANI Pharmaceuticals shares in Q1 2024, an estimated $910K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in ANI Pharmaceuticals in Q4 2015 and held it in 16 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s ANI Pharmaceuticals position peaked at $6.7M in Q4 2015.
  • 200 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.